Qube Research & Technologies (QRT)
SPPI

Qube Research & Technologies (QRT)’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-64,122
Closed -$61.6K – 4416
2023
Q2 		$61.6K Buy
+64,122
New +$63.4K ﹤0.01% 2040
2023
Q1 		– Sell
-12,582
Closed -$4.64K – 3155
2022
Q4 		$4.64K Sell
12,582
-111,787
-90% -$47.1K ﹤0.01% 2334
2022
Q3 		$53K Sell
124,369
-30,228
-20% -$29.7K ﹤0.01% 2125
2022
Q2 		$121K Buy
+154,597
New +$136K ﹤0.01% 1874
2022
Q1 		– Sell
-44,132
Closed -$56K – 3190
2021
Q4 		$56K Buy
+44,132
New +$78.9K ﹤0.01% 2239
2021
Q3 		– Sell
-84,158
Closed -$316K – 2947
2021
Q2 		$316K Buy
+84,158
New +$292K ﹤0.01% 1546
2021
Q1 		– Sell
-15,400
Closed -$53K – 2543
2020
Q4 		$53K Sell
15,400
-37,622
-71% -$155K ﹤0.01% 1693
2020
Q3 		$216K Buy
+53,022
New +$202K ﹤0.01% 1366

Qube Research & Technologies (QRT)'s SPPI Position: Q3 2023 in Review

Qube Research & Technologies (QRT) sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 64,122 shares — an estimated $61.6K sold.

Qube Research & Technologies (QRT) first reported a position in SPPI in Q3 2020 and held it in 8 quarters. The position peaked at $316K in Q2 2021. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Qube Research & Technologies (QRT) reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 64,122 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $61.6K.
  • Qube Research & Technologies (QRT) first reported a position in Spectrum Pharmaceuticals Inc in Q3 2020 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Spectrum Pharmaceuticals Inc position peaked at $316K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.